Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C3AR1 | Q16581 | 1/20 | 0.47 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KLK7 | P49862 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 7/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GNPAT | O15228 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24805405 | 0.89 | C3AR1 (0.48) | C3AR1SHMT1CTDSP1MEN1KMT2A | |
| SCHEMBL31184339 | 0.88 | FOLH1 (0.39) | C3AR1SHMT1CTDSP1MEN1KMT2A | |
| SCHEMBL5497855 | 0.82 | C3AR1 (0.55) | C3AR1SHMT1CTDSP1MEN1KMT2A | |
| SCHEMBL5497852 | 0.82 | C3AR1 (0.55) | C3AR1SHMT1CTDSP1MEN1KMT2A | |
| SCHEMBL29982298 | 0.81 | FOLH1 (0.49) | FOLH1NOD1GNPAT | |
| SCHEMBL468877 | 0.81 | FOLH1 (0.51) | C3AR1SHMT1CTDSP1MEN1KMT2A | |
| SCHEMBL468875 | 0.81 | FOLH1 (0.51) | C3AR1SHMT1CTDSP1MEN1KMT2A | |
| SCHEMBL29476375 | 0.81 | NOD1 (0.47) | FOLH1NOD1 | |
| SCHEMBL28919107 | 0.81 | MEN1 (0.43) | C3AR1SHMT1CTDSP1MEN1KMT2A | |
| SCHEMBL31184484 | 0.80 | NPY4R (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025042770-A1 | ANOREXIA-SENSITIZING AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-02-27 | — | — | WO | disclosed |
| US-20240391954-A1 | MC4R AGONIST PEPTIDES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391954-A1 | MC4R AGONIST PEPTIDES | MC4R, MC3R, MC5R | C3AR1 2341/4885SHMT1 3594/4885CTDSP1 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.